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Drosophila melanogaster and Caenorhabditis ele-
gans each carry a single representative of the Fork-
head box O (FoxO) family of transcription factors,
dFOXO and DAF-16, respectively. Both are required
for lifespan extension by reduced insulin/Igf sig-
naling, and their activation in key tissues can extend
lifespan. Aging of these tissues may limit lifespan.
Alternatively, FoxOs may promote longevity cell non-
autonomously by signaling to themselves (FoxO to
FoxO) or other factors (FoxO to other) in distal tis-
sues. Here, we show that activation of dFOXO and
DAF-16 in the gut/fat body does not require dfoxo/
daf-16 elsewhere to extend lifespan. Rather, in
Drosophila, activation of dFOXO in the gut/fat body
or in neuroendocrine cells acts on other organs to
promote healthy aging by signaling to other, as-yet-
unidentified factors. Whereas FoxO-to-FoxO sig-
naling appears to be required for metabolic homeo-
stasis, our results pinpoint FoxO-to-other signaling
as an important mechanism through which localized
FoxO activity ameliorates aging.
INTRODUCTION
Forkhead box O (FoxO) transcription factors (TFs) are involved in
a plethora of cellular processes to regulate whole-organism
physiology and are major determinants of animal lifespan (Par-
tridge and Bru¨ning, 2008; Salih and Brunet, 2008). Activation of
FoxO-family TFs mediates the lifespan-extending effects of
dampened insulin/insulin-like growth factor-like signaling (IIS)
in both worms and flies (Kenyon et al., 1993; Slack et al., 2011;
Yamamoto and Tatar, 2011). This evolutionary conservation
appears to extend to humans, because certain genetic variants
of Foxo3A are robustly associated with human longevity (Flachs-
bart et al., 2009; Kuningas et al., 2007; Willcox et al., 2008).
Indeed, Forkhead-like TFs can even extend lifespan in a
single-celled eukaryote, budding yeast (Postnikoff et al., 2012).
In Drosophila melanogaster, tissue-restricted activation of
Drosophila foxo (dfoxo) is sufficient to extend lifespan (Demontis608 Cell Reports 6, 608–616, February 27, 2014 ª2014 The Authorsand Perrimon, 2010; Giannakou et al., 2004; Hwangbo et al.,
2004). Such an increase in dfoxo activity confined to key tissues
could promote whole-organism survival in twomutually compat-
ible ways: cell autonomously and cell nonautonomously. The life-
span of the animal could be limited by pathology in a particular
organ, so that cell-autonomous action of dfoxo in that organ
alone could promote longevity (Rera et al., 2013). In addition,
healthy aging may involve the coordinated action of multiple
organ systems, with dfoxo in one organ altering whole-organism
physiology through systemic changes (Demontis and Perrimon,
2010; Hwangbo et al., 2004; Rera et al., 2013). For example,
adult-onset induction of dfoxo in the midgut and abdominal fat
body (equivalent to mammalian liver and adipose) activates the
transcription of Drosophila insulin-like peptide (dilp) 6 in the fat
body, whereas in muscle dfoxo represses the activin ligand
dowdle, and these endocrine signals have a distal effect on the
median neurosecretory cells (mNSCs) in the brain, resulting in
lowered DILP2 peptide in circulation (Bai et al., 2012, 2013).
Importantly, upregulation of dilp6 is required for the beneficial
effect of dfoxo on lifespan (Bai et al., 2012). However, whether
this requires dfoxo in tissues other than the ones producing the
DILP6 signal remains unexamined.
The single Caenorhabditis elegans FoxO ortholog, DAF-16,
can act both cell autonomously and cell nonautonomously to
regulate gene expression (Libina et al., 2003; Murphy et al.,
2007; Qi et al., 2012; Zhang et al., 2013). DAF-16 activity in one
tissue can induceDAF-16 activity in another in a process of tissue
entrainment mediated by altered expression of an insulin-like
peptide (Murphy et al., 2007), which is highly reminiscent of the
situation in the fly. For this reason, it has been widely believed
that the fruit fly’s dfoxo acts from specific cells to activate dFOXO
in thewhole animal in an instance ofdfoxo-to-dfoxo signaling (Bai
et al., 2012, 2013; Demontis and Perrimon, 2010; Hwangbo et al.,
2004). However, the relevance of this tissue entrainment for
Drosophila lifespan has not been experimentally tested. Indeed,
there is a growing awareness that FoxOs in one tissue can also
signal to other factors elsewhere, i.e., FoxO-to-other signaling.
In the worm, DAF-16 activity in one tissue can elicit daf-16-inde-
pendent responses in the receiving tissues (Qi et al., 2012; Zhang
et al., 2013). The existence and relevance of dfoxo-to-other inter-
tissue signaling is unexplored in Drosophila.
Here, we establish the relevance to aging of the cell-nonauton-
omous effects of dfoxo, differentiating between dfoxo-to-dfoxo
and dfoxo-to-other signaling in adult Drosophila. We find that
dfoxo-to-dfoxo signaling does not affect aging and confirm
that the same is true of the worm daf-16. On the other hand,
dfoxo in the gut and fat body can promote health of the neuro-
muscular system, possibly via transcriptional regulation of a
secreted neuropeptide-like molecule, and dfoxo in mNSCs can
extend lifespan. Both effects are independent of dfoxo’s
presence in other tissues, demonstrating the relevance of
dfoxo-to-other signaling in Drosophila aging. At the same time,
dfoxo-to-dfoxo signaling is required for the metabolic effects of
localized dfoxo induction, showing that distinct physiological
effects of tissue-restricted dfoxo activation are mediated by
different signaling routes.
RESULTS
dfoxo-to-dfoxo Signaling in Drosophila Is Dispensable
for Extension of Lifespan by Gut/Fat Body or mNSC
dfoxo
To examine whether activation of dFOXO in other tissues con-
tributes to the lifespan-extending effects of induction of dfoxo
in the adult gut and fat body, we generated strains where the tis-
sue-restricted induction of dfoxo could be triggered by the
RU486 inducer in either an otherwise wild-type or a dfoxo-null
background (S1106>dfoxo or dfoxoD/D S1106>dfoxo). We
used females, where the effects of dfoxo activation on aging
are clearly observed (Giannakou et al., 2004). Because the life-
span effects of ectopic dfoxo expression can be conditional on
the nutritional status of the animal (Bai et al., 2012; Min et al.,
2008), we used a food with the optimal amount of dietary yeast
(10% weight/volume) for lifespan under our laboratory condi-
tions (Bass et al., 2007) and where expression of dfoxo targeted
to adult gut and fat body robustly extends lifespan (Giannakou
et al., 2008). Importantly, on this food, lifespan is maximized so
that the effects of dfoxo can be studied as additional to the bene-
ficial effects of the diet.
We found no detectable expression of dFOXO protein or of
dfoxo transcript in the dfoxoD/D S1106>dfoxo females in the
absence of the inducer (Figures 1A and 1B). Feeding RU486
for 5 days resulted in equivalent increases in dfoxo transcript in
S1106>dfoxo and dfoxoD/D S1106>dfoxo females (Figure 1B;
see Table 1 for detailed statistical analysis). The S1106 driver
has been thoroughly characterized and, in the female fly, only
drives expression in the gut and fat body (Poirier et al., 2008).
To ensure the flies are experiencing the same nutritional condi-
tions, we examined their feeding behavior with the proboscis-
extension assay (Wong et al., 2009) and found no significant
differences (Figure S1A).
We examined the effect on lifespan resulting from the pres-
ence of the inducer in the S1106>dfoxo and dfoxoD/D
S1106>dfoxo lines in two sequential, independent, experimental
trials (Figure 1C), recording deaths of over 1,000 flies in total. The
presence of RU486 from day 2 of adulthood extended the
median lifespan of S1106>dfoxo females on average by 6%
(log-rank test p < 0.05 for each trial; Figure 1C). The magnitude
of the effect was less than previously reported (Giannakou
et al., 2004) but is consistent with more recent work in our labo-
ratory (Giannakou et al., 2008) and with six other independentCtrials performed in the course of the last 4 years (2008–2012,
average median extension 5%; Figure S1B). The lifespan of
dfoxo-null flies was also extended by a similar percentage
(average 10%, log-rank test p < 0.05 for each trial; Figure 1C).
Thus, the presence of dfoxo in the rest of the body is not required
for the lifespan-extending effects of its induction in the gut/fat
body.
Flies lacking dfoxo have short lifespans (Figure 1C), possibly
due to developmental effects of the mutation (Slack et al.,
2011), complicating the direct comparison between effects of
RU486 in the two lines. Cox proportional hazards (CPH) is a sur-
vival analysis that allows for the significance of several covari-
ates and their interactions to be examined. To establish whether
there was any statistically significant difference in the response
of dfoxo-null and wild-type flies to RU486, we combined the
two experimental trials and analyzed the survival data using
a mixed-effects Cox proportional hazards (MECPH) model
(Table 1). Both RU486 (30% reduction in risk of death, p = 2 3
104) and the presence of genomic dfoxo (p < 1015) had a sig-
nificant effect on lifespan, but their interaction did not (p = 0.95).
The absence of a significant interaction confirms that the effect
of RU486 did not differ between the lines and hence that the
presence of dfoxo elsewhere in the body does not affect the
extension of lifespan by induction of dfoxo in the gut and fat
body. Thus, tissue entrainment through dfoxo-to-dfoxo signaling
is not required for longevity.
This result indicated that either dfoxo acts cell autonomously
to extend lifespan or that dfoxo in one tissue activates dfoxo-in-
dependent longevity-assurance mechanisms in other tissues.
The latter would occur through dFOXO-to-other signaling, as
has been observed for DAF-16 (Qi et al., 2012; Zhang et al.,
2013). To further test for dfoxo-to-other signaling, we manipu-
lated the levels of dfoxo in cells whose prominent function is
in adult endocrine signaling. mNSCs in the adult brain play
an important role in aging by producing DILP2, DILP3, and
DILP5 (Broughton et al., 2005) and possibly other endocrine
signals. Expressing dfoxo specifically in the mNSC, using a
dilp2-GAL4 driver, extended the lifespan of female flies in
both wild-type and dfoxo nulls (p < 0.01 to either control in
both backgrounds; Figure 1D; Table 1). CPH analysis found
significant effects of the genomic dfoxo (p < 1015) and its induc-
tion in dilp2GAL4>dfoxo flies (50% reduction in risk of death,
p = 2.23 105) on lifespan but no evidence for a significant inter-
action between them (p = 0.33; Table 1). This confirmed that the
effect on lifespan is independent of dfoxo in tissues other than
the mNSCs.
This longevity phenotype must represent a gain of function in
the mNSC, because the ablation of mNSCs, representing a loss
of function in these cells, requires dfoxo to extend lifespan (Slack
et al., 2011). Indeed, we observed no significant changes in the
mRNA levels of dilp2, dilp3, and dilp5 upon induction of dfoxo
in mNSCs (Figures S1C and S1D). Furthermore, we found no
changes in the mRNA levels of any dilps detectable in whole
adults (dilp2 through to dilp7), including dilp6 (Figure S1D), or
their binding partner and regulator, Imp-L2 (Alic et al., 2011b)
(Figure S1E), upon activation of dfoxo in the mNSCs, confirming
that dilp2GAL4 > dfoxo flies are not experiencing any alterations
in systemic IIS activity. Because the principal role of these cells isell Reports 6, 608–616, February 27, 2014 ª2014 The Authors 609
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Figure 1. dfoxo-to-dfoxo Signaling Is Not Required for the Antiaging Effects of Increased dFOXO Activity in the Gut/Fat Body or mNSC
(A) Western blots of dFOXO and the tubulin loading control on whole-fly protein extracts from S1106>dfoxo or dfoxoD/D S1106>dfoxo female flies in the absence
of the inducer.
(B) dfoxo transcript levels (relative to Act and with S1106>dfoxo -RU486 set to 1) in S1106>dfoxo or dfoxoD/D S1106>dfoxo female flies fed or not RU486.
(C) Survival of S1106>dfoxo or dfoxoD/D S1106>dfoxo female flies in presence or absence of RU486 determined in two experimental trials (top and bottom
panel).
(D) Survival of dilp2GAL4>dfoxo female flies, or the two genetic controls (dilp2-GAL4 or UAS-dfoxo alone), in wild-type (WT) or dfoxoD/D backgrounds.
(E) The proportion of high climbers (top panel) or combined medium and high climbers (bottom panel) in three cohorts (combined) of S1106>dfoxo or dfoxoD/D
S1106>dfoxo female flies in the presence or absence of RU486.
Note the same color code is used in (B), (C), and (E) and is given in (C). See Table 1 for statistical analysis of data in (B)–(E). Where used, box plots indicate median,
first and third quartile, data range, and outliers.See also Figure S1.in endocrine signaling, the physiological effects of dfoxo activa-
tion in the mNSCs are most likely to be mediated by dfoxo-to-
other signaling.
Gut/Fat Body dfoxo Acts at a Distance Independently of
dfoxo in Target Tissues
To further investigate the role of dfoxo-to-other signaling in fly
physiology, we examined the beneficial effects of gut/fat body610 Cell Reports 6, 608–616, February 27, 2014 ª2014 The Authorsinduction of dfoxo on the neuromuscular system, an organ sys-
tem distal to the site of dfoxo activation in our model. The ability
of flies to climb a vertical surface is a suitable physiological mea-
sure of the performance of this organ system and is susceptible
to aging (Cook-Wiens and Grotewiel, 2002). We scored the num-
ber of low, medium, and high climbers in three cohorts of15 in-
dividuals of S1106>dfoxo or dfoxoD/D S1106>dfoxo genotype
in the presence or absence of RU486 over 10 weeks.
Induction of dfoxo expression in the gut and fat body
enhanced the climbing ability of female flies throughout their life-
span, observed as an increase in the proportion of high, or com-
bined medium and high, climbers (Figure 1E). This enhancement
could be seen in both the wild-type and dfoxo-null backgrounds,
revealing that it is independent of dfoxo in other tissues. Indeed,
statistical analysis (mixed-effects ordinal logistic model, Table 1)
confirmed that the effect of RU486 (p = 1.8 3 103) and dfoxo
(p = 5.4 3 1015) were both significant but that their interaction
was not (p = 0.12). Hence, local action of dfoxo in the gut and
fat body has a beneficial effect on the performance of a distal
organ system. This could occur through systemic effects of
healthy gut and fat body or through specific signaling events.
In the latter case, its independence from dfoxo in the distal cells
is again consistent with dfoxo-to-other signaling.
Gut/Fat Body dfoxo Regulates Expression of Nplp4
In order to trigger dfoxo-to-other signaling, the gut/fat body
dfoxo may regulate the expression of a secreted factor other
than dilp6. To identify such a factor, we determined the whole-
fly, genome-wide, transcriptional changes induced by RU486
in the S1106>dfoxo flies (Table S1; Figure 2A). We found that,
besides the documented changes in dilp6 (Bai et al., 2012), in-
duction of the gut/fat body dfoxo altered the mRNA levels of
another gene encoding a signal peptide targeting its protein
product for secretion, neuropeptide-like precursor 4 (Nplp4).
The mature product of this gene is a YSY peptide of previously
unknown function (Na¨ssel and Winther, 2010). Quantitative
PCR confirmed that activation of dfoxo led to repression of this
gene (Figure 2B). Hence, Nplp4 is a candidate for a secreted
factor mediating dfoxo-to-other signaling. Interestingly, this
gene was repressed in both heads and bodies of S1106>dfoxo
females fed RU486 (p = 0.048 for RU486, p = 0.19 for body
part:RU486 interaction; Figure 2B; Table 1), whereas, as ex-
pected, the induction of dfoxo itself was confined to the body,
(p = 0.053 for body part:RU486 interaction; Figure 2C; Table 1),
indicating Nplp4 responds to dFOXO both locally and distally.
Importance of dfoxo-to-dfoxo Signaling to Drosophila
Metabolism
Although dfoxo-to-dfoxo signaling is not required for lifespan
extension, it may be required for other physiological changes
in response to the activation of dFOXO in gut and fat body. To
query the existence of these other physiological effects, we
examined whether there are transcriptional changes in response
to RU486 in S1106>dfoxo flies that do not occur in dfoxoD/D S1
106>dfoxo females. We reasoned that the genes and processes
that respond to RU486 in S1106>dfoxo flies but fail to do so in
the dfoxoD/D S1106>dfoxo females may be regulated through
dfoxo-to-dfoxo signaling.
Among the genes regulated by RU486 in S1106>dfoxo fe-
males, we identified all those for which the RU486-induced tran-
scriptional change was altered by mutation of dfoxo by finding
the genes whose transcript levels show a significant interaction
between the presence of genomic dfoxo and its induction by
RU486 in the relevant linear model (Figure 2A; Table S1). The
magnitude of fold-change for these genes was reduced on
average in dfoxoD/D S1106>dfoxo compared to S1106>dfoxoCfemales (Figure 2A), indicating they require the presence of
genomic dfoxo for correct expression. We confirmed the signif-
icance of this effect using a linear model (p = 13 107; Figure 2A
and the associated caption). Note that Nplp4 was equally
repressed in dfoxoD/D S1106>dfoxo and S1106>dfoxo females
(Table S1).
Examination of the Gene Ontology categories enriched in this
group of genes revealed ‘‘proteolysis’’ as overrepresented (p =
3.1 3 107; Table S1), hinting that protein metabolism may be
regulated through a dfoxo-to-dfoxo signal. Pursuing this lead,
we found that RU486 feeding triggered a small (12%) but
significant reduction in total protein content of S1106>dfoxo
females and that this effect was blocked by deletion of dfoxo
(Figure 2D; p = 3.1 3 103 for RU486 by genotype interaction;
Table 1). Similar significant changes were not observed in total
triglyceride, total trehalose, or total glycogen content (Fig-
ure S2A). However, due to assay variability, we cannot discount
possible subtle changes in thesemetabolites. On the other hand,
total body mass followed closely the protein content (Figure 2E;
Table 1).
Surprisingly, both deletion of dfoxo and its induction in the
gut and fat body reduced total protein content and fly weight.
The two manipulations may act in different ways. The small
size of dfoxo nulls is due to the developmental effects of the
mutation (Slack et al., 2011) and, together with their reduced
fecundity (Slack et al., 2011) (Figure S2B), could explain the
lowered body weight and protein content. On the other hand, S1
106>dfoxo was induced in adulthood and had no effect
on fecundity in either wild-type or dfoxo-null females (Fig-
ure S2B), but it had an effect on bodyweight and protein content.
Hence, the latter twometabolic phenotypes of dFOXO activation
in gut/fat body may depend on dfoxo-to-dfoxo signaling. How-
ever, because dfoxo was absent in all tissues throughout devel-
opment, we cannot exclude the possibility that the inability of
dfoxo nulls to respond to RU486, for these traits, is due to devel-
opmentally altered gut/fat body function. Note that the expres-
sion pattern of the proteolysis genes, which initially led us to
this phenotype, cannot mechanistically explain the loss of pro-
tein in S1106>dfoxo females upon RU486 feeding, because
these genes are repressed in this condition (Figure S2C), but
may rather be part of a homeostatic mechanism. Nevertheless,
the results strongly indicate the effects on lifespan and meta-
bolism of tissue-restricted activation of dFOXO can be sepa-
rated by their requirement for dfoxo-to-other or dfoxo-to-dfoxo
signaling.
daf-16-to-daf-16 Signaling in C. elegans Is Dispensable
for Extension of Lifespan by Gut daf-16
The worm intestine serves a functionally similar role to the gut
and fat body in Drosophila. It is an important daf-16 signaling
center, and increased DAF-16 activity in this organ activates
DAF-16 elsewhere (Libina et al., 2003;Murphy et al., 2007). How-
ever, in the context of reduced IIS resulting from mutation in
daf-2, daf-16 presence solely in the intestine is sufficient sub-
stantially, but not completely, to restore the daf-2 mutant
longevity in otherwise daf-16-deficient worms (Libina et al.,
2003). This indicates that the observable daf-16-to-daf-16
signaling is not essential for lifespan extension. However, theell Reports 6, 608–616, February 27, 2014 ª2014 The Authors 611
Table 1. Statistical Analysis
Relevant Figure Model and Description Random Effect Coefficienta Estimateb SE p Value
Figure 1B mixed-effects linear
n = 7–8 batch intercept 0.81 0.15 0.11
dfoxo 0.571 7.1 3 102 <104
RU486 0.311 7.1 3 102 2.0 3 104
dfoxo:RU486 6.6 3 102 7.1 3 102 0.36
Figure 1C MECPH
1,050 deaths (1,078 total) experimental trial dfoxo 2.1 0.11 <1015
RU486 0.34 9.1 3 102 2 3 104
dfoxo:RU486 8.5 3 103 0.13 0.95
Figure 1D CPH
533 deaths (545 total) NA dfoxo 3.26 0.22 <1015
UAS-dfoxo 0.23 0.15 0.13
dilp2GAL4>dfoxo 0.65 0.15 2.2 3 105
dfoxo:UAS-dfoxo 0.28 0.21 0.19
dfoxo:dilp2GAL4>dfoxo 0.21 0.22 0.33
Figure 1E mixed-effects ordinal logistic
total observations = 2,179 biological repeat (vial) time 7.1 3 102 7.8 3 103 <1015
dfoxo 2.1 0.27 5.4 3 1015
RU486 0.81 0.26 1.8 3 103
time:dfoxo 5.4 3 103 9.8 3 103 0.58
time:RU486 2.9 3 103 0.01 0.78
dfoxo:RU486 0.59 0.38 0.12
time:dfoxo:RU486 8.1 3 103 1.3 3 102 0.54
Figure 2B linear
n = 5 NA intercept 3.4 0.25 <104
head 2.6 0.25 <104
RU486 0.54 0.25 4.8 3 102
head:RU486 0.34 0.25 0.19
Figure 2C linear
n = 5 NA intercept 2.8 0.25 <104
head 1.2 0.25 <104
RU486 0.38 0.25 1.8 3 102
head:RU486 0.28 0.25 5.4 3 102
Figure 2D mixed-effects linear
n = 8–10 batch intercept 0.12 1.4 3 102 6.8 3 102
dfoxo 1.7 3 102 1.8 3 103 <104
RU486 5.5 3 103 1.8 3 103 4 3 103
dfoxo:RU486 5.7 3 103 1.8 3 103 3.1 3 103
Figure 2E mixed-effects linear
n = 27–30 batch intercept 1.6 0.03 <104
dfoxo 9.6 3 102 1.3 3 102 <104
RU486 3.8 3 102 1.3 3 102 3.3 3 103
dfoxo:RU486 2.6 3 102 1.3 3 102 0.04
Figures 3A and S3A MECPH
944 deaths (1,128 total) experimental trial daf-16 2.5 0.11 <1015
intestinal daf-16 1.3 0.10 <1015
daf-16:intestinal daf-16 1.1 0.14 2 3 1015
(Continued on next page)
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Table 1. Continued
Relevant Figure Model and Description Random Effect Coefficienta Estimateb SE p Value
Figure 3B linear
n = 8–16 NA intercept 0.52 7.9 3 103 <104
daf-16 2.3 3 102 7.9 3 103 <104
intestinal daf-16 3.7 3 102 7.9 3 103 6.2 3 103
daf-16:intestinal daf-16 9.3 3 103 7.9 3 103 0.24
aIn all models, the effect of presence of dfoxo (daf-16) or its induction (overexpression) is examined; dilp2-GAL4 was used as reference for
dilp2GAL4>dfoxo and UAS-dfoxo; ‘‘body’’ was used as reference for body versus head comparisons; ‘‘:’’ indicates interaction term.
bFormixed-effect linear models and linear models, the coefficient estimates either have no units because they are derived from the dfoxo/Act orNplp4/
Act transcript ratios (for Figures 1B, 2B, and 2C) or are given in mg (for Figures 2D and 2E) or mg (Figure 3B). For MECPH and CPH models, the
coefficient estimate is the natural log of the hazard ratio, where a negative value indicates a beneficial effect on survival. For mixed-effect ordinal
logistic, these are log-transformed odds of climbing high, where a negative value indicates a reduction in climbing ability.question remains whether daf-16-to-daf-16 signaling contrib-
utes to the longevity promoted by DAF-16 alone.
To investigate this, we tested for a role of daf-16-to-daf-16
signaling in longevity induced by daf-16 overexpression in the
intestine. Increasing DAF-16 activity alone, within otherwise
wild-type worms, has two opposing effects on lifespan. DAF-
16 stimulates germline hyperplasia in a cell-nonautonomous
manner (Qi et al., 2012). This shortens the animal’s lifespan
and masks the second, prolongevity effect of DAF-16 (Qi et al.,
2012). Indeed, semiubiquitous overexpression of daf-16 extends
lifespan only if the germline cell proliferation is blocked, e.g.,
by administration of 5-fluoro-20-deoxyuridine (FUdR) (Qi et al.,
2012).
Similar to Qi and coworkers, we used FUdR to reveal the life-
span extension caused by overexpression of daf-16 from the in-
testinal-specific ges-1 promoter in otherwise wild-type worms
and asked whether this effect required the presence of daf-16
in other tissues (Figure 3A). We found that intestinal activation
of DAF-16 can extend lifespan of both wild-type and daf-16-defi-
cient (daf-16(mu86)) worms fed HT115 bacteria (log-rank p <
0.05 in three out of five and three out of three assays, respec-
tively; Figures 3A and S3A). We confirmed these findings using
a second, independently derived transgene (Figure S3B).
Upon further examination, we found that the ability of the in-
testinal daf-16 to extend wild-type lifespan was conditional on
the food source and had a small but opposite effect when worms
were fed on OP50 bacteria (Figure S3C). This is similar to the
effect of gut/fat body expression of dfoxo onDrosophila lifespan,
which can depend on available nutrition (Bai et al., 2012; Min
et al., 2008). Importantly, however, the ability of the intestinal
daf-16 to extend lifespan in the absence of daf-16 elsewhere
was observed under all conditions, including the worms fed
OP50 (Figures 3 and S3A–S3C). MECPH analysis of the com-
bined data obtained with one of the transgenes on HT115 bacte-
ria (Figures 3 and S3A) confirmed that both the effects of daf-16
presence in the whole worm and its intestinal induction were sig-
nificant (p < 1015 for both) and revealed a significant interaction
of the two main effects (p = 2 3 1015; Table 1). Thus, intestinal
daf-16 extended the lifespan of the mutant more than that of the
wild-type worms (Figure 3), confirming that, as in the fly (Fig-
ure 1C) and during IIS dampening in the worm (Libina et al.,
2003), tissue entrainment through daf-16-to-daf-16 signaling isCnot required for lifespan extension and, indeed, could even
have the opposite effect.
Prompted by the findings in the fly (Figure 2D), we also exam-
ined if the induction of intestinal daf-16 in worms had an effect on
their total protein content. We found that the intestinal daf-16
reduced whole-worm protein content (p < 104; Figure 3B;
Table 1) on HTT15 bacteria. In contrast to the fly, we found no
evidence that this reduction is prevented by the absence of
daf-16 in other tissues, and, in fact, found that mutation of
daf-16 increases the overall protein content (Figure 3B; Table 1).
We obtained similar results with the second transgene (Fig-
ure S3D). Hence, this phenotype is mediated either cell autono-
mously by daf-16 in the intestine or through daf-16-to-other
signaling. Thus, whereas the physiological effect appears
conserved between the fly and worm, the way it is mediated
differs.
It is also of note that, similar to the lifespan effect of intestinal
daf-16 in an otherwise wild-type worm, we found this modulation
of protein content conditional on the bacterial food source and
neither the transgenes nor mutation of daf-16 had any significant
effect whenwormswere fed OP50 bacteria (data not shown). For
both lifespan and protein content, the alteration of phenotype
between OP50 and HTT15 is reminiscent of the lifespan effects
of certain sensory mutants in C. elegans (Maier et al., 2010) and
suggests that intestinal DAF-16 plays a role in food perception.
DISCUSSION
In the fly, tissue-restricted dFOXO triggers endocrine factors to
cause a drop in overall, systemic, IIS activity (Bai et al., 2012,
2013; Demontis and Perrimon, 2010; Hwangbo et al., 2004).
Because insulin signals repress the activity of FoxOs (Brunet
et al., 1999), this will result in body-wide activation of dFOXO (tis-
sue entrainment), including further activation of dFOXO in the
specific tissue (positive feedback). Our results show that the tis-
sue entrainment is not required for the beneficial effects of dfoxo
on lifespan or on healthspan. The regulation of systemic IIS by
local dfoxo can still be relevant to lifespan as part of a positive
feedback loop. For example, the upregulation of dilp6 by dFOXO
in the fat body triggers a reduction in global IIS activity, and this,
in turn, could be affecting lifespan by fine-tuning the activity of
dFOXO in the fat body itself.ell Reports 6, 608–616, February 27, 2014 ª2014 The Authors 613
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Figure 2. Transcriptional Regulation by Gut/Fat Body dfoxo and the Physiological Relevance of dfoxo-to-dfoxo Signaling
(A) Log2 fold change in transcript levels upon RU486 administration in S1106>dfoxo (x axis) or dfoxoD/D S1106>dfoxo (y axis) female flies for the genes
significantly changed in S1106>dfoxo. Red indicates the genes whose response to RU486 is significantly altered by genotype (significant genotype:RU486
interaction in the linear model). The red line is the regression line for these genes (slope = 0.49) and the black line is for the others (slope = 0.77). The significant
difference in slope (p = 13 107) indicates the genes marked in red are overall less responsive to RU486 in dfoxoD/D S1106>dfoxo than in S1106>dfoxo female
flies. Gene lists are given in Table S1.
(B) Nplp4 transcript levels (relative to Act and with body -RU486 set to 1) in bodies or heads of S1106>dfoxo female flies fed or not RU486.
(C) dfoxo transcript levels (relative to Act and with body -RU486 set to 1) in bodies or heads of S1106>dfoxo female flies fed or not RU486.
(D) Protein content of individual S1106>dfoxo or dfoxoD/D S1106>dfoxo female flies after 5-day feeding with RU486 or not.
(E) Individual fly weight for the same conditions.
Note the same color code is used in (B)–(E) and is given in (B). In (D) and (E), asterisk indicates significant difference at p < 0.05 by post hoc, pair-wise t test
between  and + RU486 conditions. See Table 1 for statistical analysis of data in (B)–(E). See Figure S2 for further data.Under certain experimental conditions, the lifespan effects of
ectopic dfoxo expression can be conditional on the nutrients
available to the animal (Bai et al., 2012; Min et al., 2008). Hence,
tissue entrainment may also have conditional relevance. In addi-
tion, our results indicate that dfoxo-to-dfoxo signaling is required
for the metabolic effects of localized dfoxo induction, namely a
drop in protein content and fly weight, and further examination
may reveal roles for dfoxo-to-dfoxo signals in yet other aspects
of physiology.
Both DAF-16 in C. elegans and dFOXO in Drosophila can
extend lifespan from the gut/fat body without being present in
other tissues. The gut and/or fat body may represent the organs
most vulnerable to aging, so that DAF-16/dFOXO directly pre-
vents the otherwise lethal age-related pathologies in these
organs. This, in turn, could have indirect benefits for other
organs. Indeed, there is some evidence that the health of the614 Cell Reports 6, 608–616, February 27, 2014 ª2014 The AuthorsDrosophila gut limits lifespan (Rera et al., 2013). Furthermore,
DAF-16/dFOXO could regulate key metabolic genes in these
tissues, such as lipases, fatty acid catabolic genes, and others,
effecting a shift in energy utilization toward prolonged health
and survival. However, dFOXO activity in other tissues, such as
the muscle (Demontis and Perrimon, 2010) or the mNSC (Fig-
ure 1D), can also extend lifespan. Although it is conceivable
that multiple tissues independently and simultaneously limit life-
span, in at least some of these interventions, the relevant effects
must be cell nonautonomous.
DAF-16 in one tissue is known to trigger DAF-16-independent
responses in other tissues (Qi et al., 2012; Zhang et al., 2013). In
one case, this is mediated by induction of a transcriptional medi-
ator, mdt-15, and is required in part for the beneficial effects of
the intestinal activation of DAF-16 by daf-2() on whole-organ-
ism aging (Zhang et al., 2013). Our results indicate that dFOXO
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Figure 3. daf-16-to-daf-16 Signaling Is Not Essential for the Lifespan
Benefit of Increased DAF-16 Activity in the Intestine
(A) Survival of wild-type (WT) and daf-16(mu86) worms in combination with
daf-16 overexpression from a gut-specific promoter (muEx211[ges-1p::
GFP::daf-16]) determined in two experimental trials (top and bottom panel) in
worms fed HT115 bacteria.
(B) Worm protein content under the four conditions described in (A).
Color codes are the same in (A) and (B). See Figure S3A for further lifespan
trials and Table 1 for statistical analysis. See also Figures S3B and S3D for the
effect of an independent transgene. See Figure S3C for the lifespan effects on
OP50 bacteria.may also initiate dfoxo-independent processes in the receiving
tissues that counteract whole-organism aging. This is the most
likely mechanism whereby its activity in the Drosophila mNSC
can extend lifespan, and a similar mechanism may underlie the
health benefits observed when it is induced in the gut and fat
body. The search for the factors that mediate this effect ofCdFOXO at a distance is now of interest, and we identified
Nplp4 as a candidate. The evolutionary persistence of this
FoxO-to-other signaling between the fly and the worm strongly
suggests that its relevance may extend to mammals.EXPERIMENTAL PROCEDURES
Fly Husbandry and Experiments
All transgenes and the dfoxo mutant were backcrossed at least six times into
the wild-type outbred Dahomey population carrying the w1118 mutation and
cured of Wolbachia infection and frequently outcrossed back into the wild-
type population. The Dahomey stock was collected in 1970 in Dahomey
(now Benin) and has been kept in population cages maintaining its lifespan
and fecundity at levels similar to freshly caught stocks. The lines were main-
tained, and all experiments performed, at 25C with 60% humidity and
12 hr:12 hr light:dark cycle on sugar-yeast-agar (1SYA) food (Bass et al.,
2007). Experimental flies developed at standardized densities and once-
mated females were sorted on day 2 of adulthood onto food containing
200 mM RU486 (Sigma) or control food as required (15 per vial for climbing
assays, five for feeding, and ten for all others). Flies were harvested on day 7
for weight and metabolite measurements and protein and RNA analysis.
Sample preparation and hybridizations to Dros2 Affymetrix arrays were per-
formed and data analyzed with LIMMA, essentially as described elsewhere
(Alic et al., 2011a). For further details, see Supplemental Experimental Proce-
dures. Gene lists are given in Table S1.Worm Husbandry and Experiments
Worms were maintained at 20C unless otherwise indicated. Prior to ex-
periments, animals were maintained at the permissive temperature and
grown for at least one generation in the presence of food to assure full
viability. Lifespan assays were performed on HT115 bacteria carrying
empty pL4440 vector, or OP50 bacteria, in the presence of 10 mM FUdR.
Worms were placed on these plates at the L4 stage and scored as dead
or alive every 2–3 days. For further details, see Supplemental Experimental
Procedures.Statistical Analysis
Analyses were performed in JMP (SAS) or R. Further details are given in Table 1
and Supplemental Experimental Procedures. To determine difference in
slopes of the regression lines between the two gene sets in Figure 2A, the linear
model was fitted with RU486-induced response in dfoxoD/D S1106>dfoxo as
the dependent variable and the response in S1106>dfoxo (continuous) and
gene set (categorical) as explanatory variables, testing for the significance of
the interaction term.ACCESSION NUMBERS
The ArrayExpress accession number for the array data reported in this paper is
E-MTAB-1232.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
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